theter to allow for localized cooling. Drs. Ahlering and Finley believe that therapeutic cooling of the prostate gland and surrounding areas during prostate surgery (which includes both traditional open surgical approaches and the newer robotic-assisted technique) offers the potential to reduce tissue damage and inflammation and thereby provide a faster return of bladder control (continence) and possibly erectile function (potency) following surgery.
"We are pleased that Dr. Ahlering, one of the nation's experts in the field of robotic-assisted prostate surgery, had the opportunity to present his findings of the benefits of cooling during robotic-assisted prostatectomy and to introduce InnerCool's new investigational UroCool(TM) catheter system to other experts in his field. In late 2008, we announced the licensing of UroCool related technology from the University of California, Irvine, patient enrollment in the Hypothermic Radical Prostatectomy study being conducted by Dr. Ahlering and his associates, and our plans to submit a regulatory application for FDA 510(k) clearance for the new UroCool(TM) catheter in first quarter 2009," stated Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium Therapeutics and InnerCool Therapies.
According to the American Cancer Society, prostate cancer is the most common cancer in American men other than skin cancers. One in six men will develop prostate cancer in their lifetime, and in 2007 over 200,000 men were newly diagnosed with the disease. Fortunately, prostate cancer grows relatively slowly and 7 out of 10 men are diagnosed in the early stages of the disease before it has spread to other parts of their body, thus leading to significantly increased survival with proper treatment. While the underlying cause for the development of prostate cancer is still unknown, factors such as age, race, and lifestyle affect the probabiPage: 1 2 3 4 5 6 7 8 Related biology technology :1
. OpenClinica to Present at International Conference on Health Informatics, January 14-17, Porto, Portugal2
. Palomar and Q-MED AB Terminate International Distribution Agreement3
. Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar4
. PAREXEL International to Present at the 27th Annual JP Morgan Healthcare Conference5
. ASM International N.V. and SAFC Hitech(TM) Sign Certified Manufacturer and Partnership Agreement6
. Health Robotics Announces Partnership in the Peoples Republic of China With The Devon International Group7
. Probiotic Delivery Technology Awarded Third International Patent8
. Pressure BioSciences, Inc. and Omni International Announce Marketing, Distribution, and Technology Development Agreement9
. The International Society for Stem Cell Research Releases New Guidelines to Shape Future of Stem Cell Therapy10
. Health Robotics Announces $60M Investment by Devon International Group and ITOCHU Inc. in the CytoCare(TM) and i.v.Station(TM PENDING) Robots11
. MINRAD International, Inc. Announces Reduction in Workforce